Pyrimethamine Prior Authorization Criteria - Medicare Part D
Medicare Utilization Management Policy
Version Date: January 1, 2025
Prior Authorization Criteria for Approval
Pyrimethamine will be approved when ALL of the following are met:
- The patient has an FDA labeled indication or an indication that is supported in CMS approved compendia for the requested medication
AND - The patient does NOT have any FDA labeled contraindications to the requested medication
AND - The requested dose is within FDA labeled dosing or supported in CMS approved compendia dosing for the requested indication
Length of Approval: 6 months